Basel, Switzerland, July 17, 2017 – Clinerion and Cisiv have formed a partnership to offer an approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC).
Clinerion’s Patient Recruitment System applies informatics methodologies to extract and interpret information from EHRs, aggregating healthcare information across institutions, and geographies to create one single, comprehensive real-time view.
Clinerion’s ability to screen EHR data, including coded information, data and free text, will integrate with Cisiv’s platform, Baseline Plus, to create a novel formula. The partnering of both companies’ patented technologies will reduce the data entry burden to physicians participating in observational studies, improve data quality, and enable smooth and rapid data collection in real-world settings.
“Working with Clinerion forms an important part of Cisiv's strategy to provide a platform that combines structured prospective data capture with near real-time extraction from a broad range of data sources. Clinerion's innovative technology is a great fit with Cisiv's unique approach to real world data, which is why we are very excited about this new partnership,” says Dominic Farmer, CEO of Cisiv.
“Offering new ways to simplify data collection for studies aligns perfectly with Clinerion’s overall goal of creating new efficiencies in the entire clinical trial process, saving time and costs in the development of new drugs, and speeding up the delivery of new medicines to the patients who need them,” says Ulf Claesson, CEO, Clinerion.
For more information, please contact:
Florence Barkats
Commercial Director
Cisiv, Ltd.
12th Floor, CI Tower, St George’s Square, New Malden, KT3 4HG, United Kingdom
Tel: +44 (0) 208 939 8470
For more information, please contact:
Le Vin Chin
Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Tel.: +41 61 865 60 54
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.